References
Thigpen JT: Chemotherapy for advanced ovarian cancer: overview of randomized trials. Semin Oncol 2000, 27:11–16.
Muggia FM, Brady PS, Brady MF, et al.: Phase III randomized trial of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with advanced ovarian cancer: a GOG study. J Clin Oncol 2000, 18:106–115.
Colombo N, on behalf of ICON collaborators: Randomized trial of paclitaxel and carboplatin versus a control arm of carboplatin or CAP (ICON 3) [abstract]. Proc ASCO 2000, 19:379a.
Finkler N, Gordon A, Crozier M, et al.: Phase 2 evaluation of OSI-774, a potent oral antagonist of the EGFR-TK in patients with advanced ovarian cancer [abstract]. Proc ASCO 2001, 20:208a.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaye, S.B. Combination chemotherapy for ovarian cancer-lessons not yet learned?. Curr Oncol Rep 4, 185–186 (2002). https://doi.org/10.1007/s11912-002-0013-3
Issue Date:
DOI: https://doi.org/10.1007/s11912-002-0013-3